The ratios of CD38+ B-cells among CD19+CD27+ memory B-cells and CD19+ B-cells tended to increase in SLE patients, suggesting peripheral B-cells are in the activation state in SLE patients. This evidence concerns the gene CD19 and systemic lupus erythematosus.